Fiji vs Mauritania: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Mauritania
100.0%
in 2023
Fiji rank
1st
Mauritania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Mauritania
How they compare
Fiji currently reports 100.0% against 100.0% in Mauritania, a difference of 0.0%.
The two have swapped places 5 times across 11 shared years of data; in 2006 it was Fiji ahead.
Fiji ranks 1st and Mauritania ranks 1st of 180 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Mauritania in 1.
Head to head by decade
| Decade | Fiji | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 4.5% | 95.5% | Fiji |
| 2010s | 69.3% | 44.7% | 24.6% | Fiji |
| 2020s | 77.2% | 100.0% | 22.8% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Mauritania?
- Fiji, at 100.0% against 100.0% in Mauritania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Mauritania?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Mauritania?
- 11 years are reported by both, from 2006 to 2023.
- How do Fiji and Mauritania rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Mauritania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.